Chromadex CorpNASDAQ:CDXC
- LAST PRICE3.4450
- TODAY'S CHANGE (%)0.0550 (1.6224%)
- Bid / Lots3.4300/ 2
- Ask / Lots3.4600/ 4
- Open / Previous Close3.3800 / 3.3900
- Day Range
- 52 Week Range
- Volume119,699
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | CDXC |
|---|---|---|
| 09:32 ET | 4130 | 3.38 |
| 09:36 ET | 400 | 3.43 |
| 09:38 ET | 1083 | 3.42 |
| 09:39 ET | 1423 | 3.39 |
| 09:41 ET | 900 | 3.38 |
| 09:43 ET | 284 | 3.42 |
| 09:52 ET | 100 | 3.42 |
| 09:54 ET | 610 | 3.42 |
| 10:03 ET | 456 | 3.4174 |
| 10:06 ET | 1000 | 3.4289 |
| 10:08 ET | 299 | 3.43 |
| 10:12 ET | 100 | 3.43 |
| 10:14 ET | 710 | 3.425 |
| 10:15 ET | 100 | 3.44 |
| 10:17 ET | 1060 | 3.46 |
| 10:19 ET | 1300 | 3.47 |
| 10:26 ET | 150 | 3.4691 |
| 10:28 ET | 100 | 3.47 |
| 10:32 ET | 500 | 3.4659 |
| 10:33 ET | 173 | 3.47 |
| 10:35 ET | 400 | 3.485 |
| 10:37 ET | 1494 | 3.49 |
| 10:39 ET | 10326 | 3.5 |
| 10:44 ET | 1637 | 3.52 |
| 10:46 ET | 3392 | 3.503 |
| 10:48 ET | 250 | 3.505 |
| 10:51 ET | 200 | 3.52 |
| 10:57 ET | 100 | 3.52 |
| 11:00 ET | 11490 | 3.45 |
| 11:08 ET | 599 | 3.48 |
| 11:11 ET | 200 | 3.475 |
| 11:13 ET | 100 | 3.475 |
| 11:15 ET | 200 | 3.47 |
| 11:20 ET | 21473 | 3.52 |
| 11:22 ET | 900 | 3.49 |
| 11:36 ET | 300 | 3.49 |
| 11:38 ET | 118 | 3.48 |
| 11:44 ET | 3430 | 3.445 |
| 12:12 ET | 100 | 3.45 |
| 12:16 ET | 3631 | 3.45 |
| 12:18 ET | 517 | 3.44 |
| 12:21 ET | 600 | 3.4394 |
| 12:30 ET | 16280 | 3.405 |
| 12:32 ET | 290 | 3.42 |
| 12:36 ET | 200 | 3.39 |
| 12:38 ET | 200 | 3.39 |
| 12:41 ET | 100 | 3.42 |
| 12:43 ET | 100 | 3.39 |
| 12:45 ET | 100 | 3.39 |
| 12:50 ET | 100 | 3.39 |
| 12:52 ET | 100 | 3.42 |
| 12:54 ET | 2225 | 3.4008 |
| 01:10 ET | 486 | 3.44 |
| 01:17 ET | 100 | 3.46 |
| 01:21 ET | 100 | 3.46 |
| 01:26 ET | 991 | 3.47 |
| 01:28 ET | 220 | 3.47 |
| 01:32 ET | 1438 | 3.45 |
| 01:35 ET | 300 | 3.46 |
| 01:46 ET | 4055 | 3.44 |
| 01:50 ET | 416 | 3.46 |
| 01:51 ET | 386 | 3.46 |
| 02:04 ET | 836 | 3.445 |
Yesterday
ChromaDex Announces Nationwide Launch of Tru Niagen(R) at The Vitamin Shoppe(R), from 8:34AM ET on Thursday Apr 25, 2024 by Dow Jones
8:34AM ET on Thursday Apr 25, 2024 by Dow Jones
Apr 24, 2024
ChromaDex to Report First Quarter 2024 Financial Results on Wednesday, May 8, 2024, from 8:34AM ET on Wednesday Apr 24, 2024 by Dow Jones
8:34AM ET on Wednesday Apr 24, 2024 by Dow JonesPress Release: ChromaDex to Report First Quarter 2024 Financial Results on Wednesday, May 8, 2024, from 8:34AM ET on Wednesday Apr 24, 2024 by Dow Jones
8:34AM ET on Wednesday Apr 24, 2024 by Dow Jones
Apr 23, 2024
ChromaDex Announces Inaugural Major Grocery Debut of Tru Niagen(R) at Sprouts Farmers Market, from 8:32AM ET on Tuesday Apr 23, 2024 by Dow Jones
8:32AM ET on Tuesday Apr 23, 2024 by Dow Jones
Apr 9, 2024
DJ ChromaDex Is Maintained at Buy by Roth MKM, from 10:10AM ET on Tuesday Apr 09, 2024 by Dow Jones
10:10AM ET on Tuesday Apr 09, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Chromadex Corp | 255.3M | -52.3x | --- |
Enanta Pharmaceuticals Inc | 264.0M | -1.9x | --- |
G1 Therapeutics Inc | 201.5M | -4.2x | --- |
Alimera Sciences Inc | 173.3M | -1.6x | --- |
2Seventy Bio Inc | 220.1M | -1.0x | --- |
Codexis Inc | 186.3M | -2.4x | --- |
Company Information
Chromadex Corp. is a global bioscience company. The Company is engaged in research on nicotinamide adenine dinucleotide (NAD+), an essential coenzyme that is a key regulator of cellular metabolism and is found in every cell of the human body. Its segments include Consumer Products, Ingredients and Analytical Reference Standards and Services. The Consumer Products segment provides finished dietary supplement products that contain the Company's proprietary ingredients, commercialized as Tru Niagen, directly to consumers and distributors. The Ingredients segment develops and commercializes proprietary-based ingredient technologies and supplies these ingredients as raw materials to the manufacturers of consumer products. The Ingredients segment provides Niagen in ingredient form to its strategic partners. The Analytical Reference Standards and Services segment offers the supply of phytochemical reference standards and other research and development services.
Contact Information
- Headquarters
- 10900 Wilshire Blvd, Suite 600LOS ANGELES, CA, United States 90024
- Phone
- 310-388-6706
- Fax
- 302-421-5753
Executives
- Chairman of the Board
- Frank Jaksch
- Chief Executive Officer, Director
- Robert Fried
- Chief Financial Officer
- Brianna Gerber
- Lead Independent Director
- Steven Rubin
- Independent Director
- Ann Cohen
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $255.3M |
|---|---|
Revenue (TTM) | $83.6M |
Shares Outstanding | 75.3M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.98 |
EPS | $-0.07 |
Book Value | $0.38 |
P/E Ratio | -52.3x |
Price/Sales (TTM) | 3.1 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -6.70% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
